Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Animal Studies Completed for Blood Substitute

By HospiMedica staff writers
Posted on 07 Oct 2002
Key animal studies have been completed on a new perfluorcarbon-based blood substitute and therapeutic oxygen carrier.

Studies on the synthetic blood substitute, called Oxycyte, were conducted in rats and monkeys. More...
Oxycyte, developed by Synthetic Blood International, Inc. (SYBD, Costa Mesa, CA, USA), is a parenteral oxygen-carrying perfluorocarbon emulsion whose applications include blood replacement in surgery and trauma and treatment of ischemic conditions such as stroke and heart attack.

In comparison to hemoglobin, the component of blood that binds with and transports oxygen, Oxycyte can carry at least five times more oxygen. Additionally, perfluorocarbons are much more effective than hemoglobin at unloading oxygen at the tissue level, says the company. Oxycyte is inert and can be fully sterilized, meaning it is disease free. It can be stored at room temperature and does not require typing or cross-matching prior to use.

"This is an extremely important milestone for us,” said Robert Nicora, president and CEO of SYBD. "This will allow SYBD to begin Phase I clinical trials with Oxycyte in the first quarter of 2003 and phase II trials in the second quarter of 2003.” SYBD is also developing a liquid ventilation product that may be useful in treating respiratory disorders in adults and children.




Related Links:
SYBD

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.